We’re committed to our mission of finding new treatments that may help improve the lives of people with cancer. Our clinical trials for bladder cancer study investigational medications alone, or in combination with other study medications or standard of care therapy. We perform these trials to see if they can help prevent, find, or treat cancer.
The most common type of bladder cancer is urothelial carcinoma. This type of cancer begins when cells inside the urinary bladder start to grow rapidly. As more cancer cells build up, they form a tumor, which can grow through the layers of the bladder and spread to other areas of the body. When the cancer has not grown into the muscle layer of the bladder, it is called non-muscle invasive bladder cancer.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.
